Table 2.
Characteristic | No. of rRNA hits, biofilms | Total no. of hits, biofilm ORFs | Total no. of hits, supernatant ORFs | No. of unique ORFs identified, biofilm | No. of unique ORFs identified | Total no. of unique ORFs in the community | No. of rRNA hits, supernatant | Total no. of hits, biofilm IGRs | Total no. of hits, supernatant IGRs | No. of unique IGRs identified, biofilm | No. of unique IGRs identified, supernatant | Total no. of unique IGRs in the community |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy | 5,157,293 | 1,331,097 | 593,118 | 7,982 (66%) | 7,520 (62%) | 12,054 | 11,649,872 | 765,970 | 452,726 | 2,146 (24%) | 2,236 (25%) | 8,919 |
Pathogenic | 14,025,715 | 578,919 | 744,494 | 6,923 (38%) | 9,714 (53%) | 18,146 | 21,036,949 | 203,215 | 826,255 | 1,122 (9%) | 2,247 (18%) | 12,318 |
rRNA sequences were discarded from the final analysis. We present the results for protein-coding ORFs and small noncoding RNA IGRs. In parentheses, the fraction of ORFs or IGRs that were identified when compared with the total number in the metagenome.